|
MANEA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63813407283442E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-16 |
| Normal-vs-Stage2 |
5.93329996245728E-09 |
| Normal-vs-Stage3 |
7.07660000043298E-07 |
| Normal-vs-Stage4 |
3.306200E-02 |
| Stage1-vs-Stage2 |
4.862000E-01 |
| Stage1-vs-Stage3 |
6.174000E-02 |
| Stage1-vs-Stage4 |
1.283030E-01 |
| Stage2-vs-Stage3 |
3.520800E-01 |
| Stage2-vs-Stage4 |
4.210400E-01 |
| Stage3-vs-Stage4 |
7.494400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.10782519111308E-15 |
| Normal-vs-AfricanAmerican |
4.62407889756378E-12 |
| Normal-vs-Asian |
2.18579999999857E-05 |
| Caucasian-vs-AfricanAmerican |
5.596000E-01 |
| Caucasian-vs-Asian |
8.918400E-01 |
| AfricanAmerican-vs-Asian |
7.254200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
1.68629998853476E-09 |
| Male-vs-Female |
1.884970E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.57380000143093E-08 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.36250011273376E-10 |
| Normal-vs-Extreme_Obese |
4.21139999540188E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.431040E-01 |
| Normal_Weight-vs-Obese |
7.168600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.818600E-01 |
| Extreme_Weight-vs-Obese |
1.940100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.670600E-01 |
| Obese-vs-Extreme_Obese |
4.927000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.18660000003601E-06 |
| Normal-vs-Age(41-60Yrs) |
7.0743411129115E-13 |
| Normal-vs-Age(61-80Yrs) |
1.62492241884138E-12 |
| Normal-vs-Age(81-100Yrs) |
3.38890027151706E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.079800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.142200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.495900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.918100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.801300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.536030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
6.08399997048537E-10 |
| Normal-VS-KIRP CIMP |
5.434800E-04 |
| Normal-VS-Unclassified PRCC |
4.16050000007218E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.978100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.696200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.136830E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.779800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.928600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.725000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.90798504668055E-14 |
| Normal-vs-N1 |
8.682700E-03 |
| Normal-vs-N2 |
2.13740136700835E-12 |
| N0-vs-N1 |
6.097600E-03 |
| N0-vs-N2 |
2.918600E-01 |
| N1-vs-N2 |
1.043910E-03 |
|
|
